← FDA Drug Approvals (Drugs@FDA)

IBUPROFEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: YICHANG HUMANWELL · Approved 2022-03-30

Drug application

FDA Application #

ANDA215318

Application type

Abbreviated New Drug Application (Generic)

Brand name

IBUPROFEN

Generic name

IBUPROFEN

Active ingredients

IBUPROFEN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

YICHANG HUMANWELL

Manufacturer

Westminster Pharmaceuticals, LLC

First approval

2022-03-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown